KNOCKDOWN OF THE MT1 MELATONIN RECEPTOR AMELIORATES THE PHENOTYPES OF THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC) BY DOWNREGULATION OF ORPHAN GPR50 RECEPTOR-PROMOTED CONSTITUTIVE TGF-β1 RECEPTOR SIGNALING

被引：0
|
作者：
Wu, Nan
Ceci, Ludovica
Zhou, Tianhao
Francis, Heather L.
Kennedy, Lindsey
Kyritsi, Konstantina
Alvaro, Domenico
Carpino, Guido
Wu, Chaodong
Chakraborty, Sanjukta
Chen, Lixian
Baiocchi, Leonardo
Franchitto, Antonio
Ekser, Burcin
Onori, Paolo
Mancinelli, Romina
Grumbles, Kassidy
Gaudio, Eugenio
Glaser, Shannon S.
Alpini, Gianfranco
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
233
引用
收藏
页码：S768 / S768
页数：1
相关论文
共 10 条
  • [1] The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization
    Levoye, Angelique
    Dam, Julie
    Ayoub, Mohammed A.
    Guilllaume, Jean-Luc
    Couturier, Cyril
    Delagrange, Philippe
    Jockers, Ralf
    EMBO JOURNAL, 2006, 25 (13): : 3012 - 3023
  • [2] The melatonin/MT1/miR-200b axis regulates biliary senescence and liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis
    Wu, Nan
    Meng, Fanyin
    Invernizzi, Pietro
    Venter, Julie
    Bernuzzi, Francesca
    Alvaro, Domenico
    Onori, Paolo
    Franchitto, Antonio
    Zhou, Tianhao
    Francis, Heather L.
    Kyritsi, Tina
    Mancinelli, Romina
    Gaudio, Eugenio
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2016, 64 : 178A - 178A
  • [3] INHIBITION OF TRANSFORMING GROWTH FACTOR BETA 1 (TGFβ1) BY VIVO-MORPHOLINO (VM) AMELIORATES CHOLESTASIS IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Chen, Lixian
    Zhou, Tianhao
    Kundu, Debjyoti
    Meadows, Vik
    Kennedy, Lindsey
    Kyritsi, Konstantina
    Wu, Nan
    Meyer, Alison A.
    Owen, Travis M.
    Alpini, Gianfranco
    Francis, Heather L.
    GASTROENTEROLOGY, 2022, 162 (07) : S1216 - S1216
  • [4] Mast Cells Contribute to Hepatic Neurokinin1 Receptor Signaling, Subsequent Biliary Damage and Peribiliary Fibrosis Via TGF-β1 Signaling in MDR2-/- Mouse Model of Primary Scelrosing Cholangitis
    Kundu, Debjyoti
    Zhou, Tianhao
    Meadows, Vik
    Kennedy, Lindsey
    Ceci, Ludovica
    Kyritsi, Konstantina
    Glaser, Shannon
    Alpini, Gianfranco
    Francis, Heather
    FASEB JOURNAL, 2022, 36
  • [5] Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis
    Ceci, Ludovica
    Francis, Heather
    Zhou, Tianhao
    Giang, Thao
    Yang, Zhihong
    Meng, Fanyin
    Wu, Nan
    Kennedy, Lindsey
    Kyritsi, Konstantina
    Meadows, Vik
    Wu, Chaodong
    Liangpunsakul, Suthat
    Franchitto, Antonio
    Sybenga, Amelia
    Ekser, Burcin
    Mancinelli, Romina
    Onori, Paolo
    Gaudio, Eugenio
    Glaser, Shannon
    Alpini, Gianfranco
    AMERICAN JOURNAL OF PATHOLOGY, 2020, 190 (11): : 2251 - 2266
  • [6] MANIPULATION OF THE MIR-16/FGF-1 AXIS REDUCES PROFIBROTIC, PROLIFERATIVE, AND INFLAMMATORY PHENOTYPES IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    O'Brien, April
    White, Tori
    Kyritsi, Konstantina
    Francis, Heather L.
    Zhou, Tianhao
    Chakraborty, Sanjukta
    Meng, Fanyin
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2020, 72 : 309A - 310A
  • [7] Administration of Serotonin Receptor 2A/2B/2C Antagonists Decreases Ductular Reaction and Hepatic Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis (PSC).
    Kyritsi, Konstantina
    O'Brien, April
    White, Tori
    Chen, Lixian
    Meng, Fanyin
    Venter, Juliet
    Wu, Nan
    Zhou, Tianhao
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2018, 68 : 131A - 131A
  • [8] Inhibition of the substance P/neurokinin-1 receptor (NK-1R) axis decreases liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC) through changes in senescence in cholangiocytes and hepatic stellate cells
    Wan, Ying
    Zhou, Tianhao
    Wu, Nan
    Invernizzi, Pietro
    Standeford, Holly A.
    McDaniel, Kelly
    Bernuzzi, Francesca
    Venter, Julie
    Onori, Paolo
    Gaudio, Eugenio
    Franchitto, Antonio
    Sato, Keisaku
    Francis, Heather L.
    Meng, Fanyin
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2016, 64 : 824A - 825A
  • [9] LONG-TERM ADMINISTRATION OF THE SECRETIN RECEPTOR ANTAGONIST, SCT 5-27, INHIBITS BILIARY SENESCENCE AND LIVER FIBROSIS OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN THE MDR2-/- MOUSE MODEL.
    Wu, Nan
    Kennedy, Lindsey
    Zhou, Tianhao
    Kyritsi, Konstantina
    Chen, Lixian
    Ceci, Ludovica
    Grumbles, Kassidy
    Francis, Heather L.
    Meadows, Vik
    Meng, Fanyin
    Ekser, Burcin
    O'Brien, April
    Rivosecchi-Fulton, Jessica
    Onori, Paolo
    Gaudio, Eugenio
    White, Tori
    Glaser, Shannon S.
    Alpini, Gianfranco
    GASTROENTEROLOGY, 2020, 158 (06) : S1277 - S1277
  • [10] KNOCKOUT OF SECRETIN/SECRETIN RECEPTOR AXIS (SCT/SR) REDUCES LIVER FIBROSIS BY ANGIOGENESIS-DEPENDENT REDUCED SENESCENCE OF CHOLANGIOCYTES BUT INCREASED SENESCENCE OF HEPATIC STELLATE CELLS (HSCS) IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Zhou, Tianhao
    Kyritsi, Konstantina
    Wu, Nan
    Venter, Julie
    Francis, Heather L.
    Meng, Fanyin
    Chen, Lixian
    Giang, Thao
    White, Tori
    Alpini, Gianfranco
    Glaser, Shannon
    GASTROENTEROLOGY, 2018, 154 (06) : S1185 - S1185
1